Biotech | February 28, 2022
BDR Pharma launches enzalutamide in 160 mg strength
This medicine was previously available in 40mg and 80mg strength, for which patients had to consume 2 tablets a day as per the approved dosage
This medicine was previously available in 40mg and 80mg strength, for which patients had to consume 2 tablets a day as per the approved dosage
N Yuvraj, Joint Secretary, Dept of Pharmaceuticals, Satish Reddy, Chairman, Dr Reddy’s Laboratories; Kiran Mazumdar Shaw, Executive Chairperson, Biocon Group; Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines and Shravil Patel, MD, Zydus Lifesciences discuss the way forward for the India pharma industry
Eubio Isoquercetin derived from Sophora Japonica is expected to deliver more Quercetin to the body via small doses of Isoquercetin.
PSCI, a global non-profit organization, works with its members to ensure a positive environment that can improve global healthcare supply chains
Industry leaders discusses the need of innovation for the Indian drug industry at BioAsia 2022.
The Genome Valley region has played a pivotal role in fostering the life science industry and the state government has always supported its growth
Collaboration in the industry needs to be institutionalised to drive the growth.
Dr. Shah will lead strategic and operational clinical development of the company's diverse pipeline
Zerion´s innovative Dispersome technology builds on a new concept of increasing drug solubility by using natural protein-based excipients to formulate APIs into amorphous solid dispersions (ASDs) by spray drying
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
Subscribe To Our Newsletter & Stay Updated
